Trial Profile
Effects of Ezetimibe Add-On to Statin Therapy on Adipokine Production in Obese and Metabolic Syndrome Patients With Atherosclerosis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; HMG-CoA reductase inhibitors
- Indications Hypercholesterolaemia; Hyperlipoproteinaemia type II; Sitosterolaemia
- Focus Biomarker; Pharmacodynamics
- 24 Nov 2010 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 24 Nov 2010 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 24 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.